About US
Contact us
-
US FDA approves Cosentyx for ankylosing spondylitis and psoriatic arthritis treatmentSwiss drug maker Novartis has secured approvals from the US Food and Drug Administration (FDA) for injectable medication Cosentyx for two new indications, which can now be used to treat patients havin2016/1/20
-
Wockhardt spanked again by FDA as agency ticks off violations at new sterile injectables plantWockhardt saw a new plant that will make sterile injectable drugs as its best shot at restoring a U.S. business devastated byFDAproduct bans.But the Indian company said today that facility--a plant it2016/1/19
-
It's Merck vs. Merck as name confusion, complicated by social media, leads to legal showdownMerck KGaA wins U.K. ruling, but Merck & Co. says it will file its own lawsuit in U.S. Merck has won a legal battle over Merck, which in return says it will file a lawsuit against Merck. It sound2016/1/19
-
Merck agrees to acquire UK's IOmet PharmaMerck has entered into an agreement to acquire IOmet Pharma, a UK-based small-molecule drug developer focused on cancer immunotherapy and cancer metabolism, for an undisclosed price. Following comple2016/1/18
-
Sanofi and Warp Drive to develop new oncology therapies and antibioticsFrench pharmaceutical firm Sanofi has entered into a new collaboration with Warp Drive Bio, a US-based biotechnology firm using the molecules and mechanisms of nature to discover and develop transform2016/1/18
-
Boehringer and Arena to develop new drugs for psychiatric diseasesGerman pharmaceutical firm Boehringer Ingelheim has signed an exclusive agreement with US-based Arena Pharmaceuticals, to conduct joint research to discover new drug candidates for psychiatric disease2016/1/15
-
Sanofi and Warp Drive to develop new oncology therapies and antibioticsFrench pharmaceutical firm Sanofi has entered into a new collaboration with Warp Drive Bio, a US-based biotechnology firm using the molecules and mechanisms of nature to discover and develop transform2016/1/15
-
GSK chief Witty opens up to spinoff talk, with consumer health an obvious choiceGlaxoSmithKline ($GSK) CEOAndrew Wittymay be coming around on a breakup. At theJ.P. Morgan Healthcare Conference, Witty said he's open to the idea and pegged his consumer health joint venture with Nov2016/1/14
-
New Bayer site to make traditional Chinese and Western consumer health medsBayersnapped up China's Dihon in 2014 with the idea of combining Dihon's traditional Chinese medicines with Bayer's Western OTC products in a major consumer health play in the country. Now it has a la2016/1/14
-
Time for J&J to pay up in $124M Risperdal case as SCOTUS deflects final appealJohnson & Johnson ($JNJ) fell short Monday in its final effort to escape a Risperdal marketing penalty in South Carolina. TheU.S. Supreme Courtdeclined to take up J&J's last appeal in the case2016/1/13